Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease

被引：0
|
作者：
Marta Turri
Elisa Conti
Chiara Pavanello
Francesco Gastoldi
Marcella Palumbo
Franco Bernini
Vittoria Aprea
Francesca Re
Alberto Barbiroli
Davide Emide
Daniela Galimberti
Lucio Tremolizzo
Francesca Zimetti
Laura Calabresi
机构：
[1] Università Degli Studi Di Milano,Centro E. Grossi Paoletti, Dipartimento Di Scienze Farmacologiche E Biomolecolari
[2] Neurology Unit,Department of Food and Drug
[3] IRCCS “San Gerardo Dei Tintori”,School of Medicine and Surgery
[4] Monza,Dipartimento Di Scienze Per Gli Alimenti, La Nutrizione E L’Ambiente
[5] and University of Milano-Bicocca,Department of Biomedical, Surgical and Dental Sciences
[6] University of Parma,undefined
[7] University of Milano-Bicocca,undefined
[8] Università Degli Studi Di Milano,undefined
[9] University of Milan,undefined
[10] Fondazione IRCCS Ca’ Granda,undefined
[11] Ospedale Policlinico,undefined
来源：
Alzheimer's Research & Therapy | / 15卷
关键词：
Alzheimer’s disease; High-density lipoproteins; Lecithin:cholesterol acyltransferase; Cholesterol efflux; Apolipoprotein E;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Sui, Xiaojing
    Liu, Jianjun
    Yang, Xifei
    NEUROSCIENCE BULLETIN, 2014, 30 (02) : 233 - 242
  • [22] Cerebrospinal fluid biomarkers in Alzheimer's disease
    Lee, K. H.
    JOURNAL OF NEUROCHEMISTRY, 2013, 125 : 41 - 42
  • [23] Cerebrospinal fluid and plasma gamma-aminobutyric acid in Alzheimer's disease
    Weiner, MF
    Speciale, SG
    Risser, RC
    Kramer, GL
    Petty, F
    BIOLOGICAL PSYCHIATRY, 1996, 40 (09) : 933 - 934
  • [24] MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma
    Bekris, Lynn M.
    Lutz, Franziska
    Montine, Thomas J.
    Yu, Chang En
    Tsuang, Debby
    Peskind, Elaine R.
    Leverenz, James B.
    BIOMARKERS, 2013, 18 (05) : 455 - 466
  • [25] Cerebrospinal fluid biomarkers of Alzheimer's disease
    Xiaojing Sui
    Jianjun Liu
    Xifei Yang
    Neuroscience Bulletin, 2014, 30 (02) : 233 - 242
  • [26] Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease
    Arlt, S.
    Schulze, F.
    Eichenlaub, M.
    Maas, R.
    Wiedemann, K.
    Boeger, R.
    Jahn, H.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 210 - 210
  • [27] Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease
    Sun, YX
    Minthon, L
    Wallmark, A
    Warkentin, S
    Blennow, K
    Janciauskiene, S
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2003, 16 (03) : 136 - 144
  • [28] Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease
    Arlt, Soenke
    Schulze, Friedrich
    Eichenlaub, Martin
    Maas, Renke
    Lehmbeck, Jan T.
    Schwedhelm, Edzard
    Jahn, Holger
    Boeger, Rainer H.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 26 (01) : 58 - 64
  • [29] Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients
    Costa, Montserrat
    Horrillo, Raquel
    Maria Ortiz, Ana
    Perez, Alba
    Mestre, Anna
    Ruiz, Agustin
    Boada, Merce
    Grancha, Salvador
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (04) : 1395 - 1404
  • [30] Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
    Palmqvist, Sebastian
    Insel, Philip S.
    Stomrud, Erik
    Janelidze, Shorena
    Zetterberg, Henrik
    Brix, Britta
    Eichenlaub, Udo
    Dage, Jeffrey L.
    Chai, Xiyun
    Blennow, Kaj
    Mattsson, Niklas
    Hansson, Oskar
    EMBO MOLECULAR MEDICINE, 2019, 11 (12)
12345